更新：甲型肝炎病毒暴露后及国际旅行者中甲型肝炎的预防。免疫实践咨询委员会（ACIP）的更新建议。
Update: Prevention of hepatitis A after exposure to hepatitis A virus and in international travelers. Updated recommendations of the Advisory Committee on Immunization Practices (ACIP).
出版信息
MMWR Morb Mortal Wkly Rep. 2007 Oct 19;56(41):1080-4.
PMID:17947967
Abstract
In 1995, highly effective inactivated hepatitis A vaccines were first licensed in the United States for preexposure prophylaxis against hepatitis A virus (HAV) among persons aged > or =2 years. In 2005, vaccine manufacturers received Food and Drug Administration approval for use of the vaccines in children aged 12-23 months.
摘要
1995年，高效灭活甲肝疫苗首次在美国获得许可，用于2岁及以上人群暴露前预防甲型肝炎病毒（HAV）。2005年，疫苗制造商获得美国食品药品监督管理局批准，可将这些疫苗用于12至23个月大的儿童。
Zotero 插件